Jam

Gunnison Copper Project’s updated PEA reveals strong economics, with a projected $1.952 billion NPV and 22.7% IRR at $4.60/lb copper. Key enhancements include integrating the Strong & Harris deposit, material sorting, and a cement co-product, significantly boosting value by $692 million compared to the previous study. The project forecasts 174 million lbs of copper annually for 15 years, with competitive cash costs. Gunnison Copper Corp. plans to proceed with a Pre-Feasibility Study.

Toll Brothers, a luxury home builder, has been honored at The Nationals Awards by the National Association of Home Builders (NAHB). This recognition celebrates their excellence in design, construction, and customer satisfaction in the competitive real estate market. The awards highlight Toll Brothers’ sustained leadership in delivering high-quality homes and communities, reflecting their understanding of buyer preferences, innovation, and commitment to providing exceptional lifestyle experiences.

Sun Summit Corp. has successfully listed its common share purchase warrants on the TSX Venture Exchange under the symbol “SCS.WT.” This move aims to boost liquidity for warrant holders and open avenues for future capital raising. The listing provides a regulated trading platform, enhancing accessibility for investors and potentially improving Sun Summit’s market visibility and access to capital.

Latin Metals Inc. will participate in PDAC 2026, North America’s premier mineral exploration convention in Toronto, March 8-11. The company invites investors to meet its management team, providing updates on its South American copper and gold projects. PDAC offers a vital platform for Latin Metals to connect with the investment community, showcase its advancements, and discuss its strategic growth plans and commitment to responsible development.

Euroseas Ltd. reported resilient performance in Q4 and full-year 2025 amidst shifting market dynamics. The company maintained robust fleet utilization and adapted to evolving trade flows with its diverse vessel sizes. Strategic management focused on fleet modernization, emissions reduction, and prudent financial discipline, positioning Euroseas to capitalize on future opportunities in the container shipping sector.

TELUS Corporation has updated its Dividend Reinvestment Program (DRIP), a move signaling confidence in future cash flow and offering shareholders new strategic avenues. This adjustment to the program, which allows reinvesting dividends into additional company stock, comes as TELUS invests in 5G and fiber expansion. Enhanced DRIP terms, potentially including a better discount, could attract investors and bolster the company’s equity base. Shareholders are advised to review the updated terms.

Darktrace is modernizing its global travel program by partnering with Navan, a unified platform for business travel, expense, and corporate cards. This strategic move leverages Navan’s AI capabilities to streamline booking, enforce policies, and gain real-time spending insights. The goal is to enhance employee experience, drive significant cost savings, and improve operational efficiency, reflecting a broader trend of technology adoption for critical business functions.

InterContinental Hotels Group (IHG) announced a share repurchase, signaling strong confidence in its strategic direction and financial outlook. This move, a form of capital return to shareholders, aims to enhance earnings per share and potentially stabilize the stock price. It suggests IHG’s leadership sees intrinsic value and future growth opportunities, even amidst industry challenges. The buyback complements IHG’s investments in digital transformation and reflects a belief in its resilience and expansion potential within the evolving travel sector.

Tandem Diabetes Care has secured $265 million in convertible senior notes due 2032, with an option for an additional $40 million. This funding will accelerate the company’s strategic initiatives, including advancing its diabetes technology, expanding global market reach, and investing in research and development. The offering reflects strong investor confidence in Tandem’s growth trajectory and its innovative insulin delivery systems.